Racemic intrathecal mirtazapine but not its enantiomers acts anti-neuropathic after chronic constriction injury in rats

Brain Research Bulletin

Volumn 79, Issue 1, 2009, Pages 63-68

  Muth Selbach, Uta ^a   Hermanns, Henning ^a   Driehsen, Carina ^a   Lipfert, Peter ^b   Freynhagen, Rainer ^a,c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c Benedictus Krankenhaus Tutzing   (Germany)

Author keywords

Dual acting antidepressants; Enantiomers; Mirtazapine; Neuropathic pain

Indexed keywords

MIRTAZAPINE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; ENANTIOMER; ENANTIOSELECTIVITY; HYPERALGESIA; MALE; NERVE COMPRESSION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; SCIATIC NEUROPATHY;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; HOT TEMPERATURE; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MIANSERIN; NEURALGIA; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 60549114392     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.12.015     Document Type: Article

References (43)

1. Arnold P., Vuadens P., Kuntzer T., Gobelet C., and Deriaz O. Mirtazapine decreases the pain feeling in healthy participants. Clin. J. Pain 24 (2008) 116-119
2. Attal N., Cruccu G., Haanpää M., Hansson P., Jensen T.S., Nurmikko T., Sampaio C., Sindrup S., and Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. 13 (2006) 1153-1169
3. Baker G., and Prior T. Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs. Ann. Med. 34 7-8 (2002) 537-543
4. Baumann P., Jonzier-Perey M., Paus E., and Nikisch G. Mirtazapine enantiomers in blood and cerebrospinal fluid. Neuropsychobiology 54 (2006) 179-181
5. Bendtsen L., and Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62 (2004) 1706-1711
6. Bennett G., and Xie Y. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
7. Bomholt S.F., Mikkelsen J.D., and Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48 (2005) 252-263
8. Bonnefont J., Chapuy E., Clottes E., Alloui A., and Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114 (2005) 482-490
9. Burgess S.E., Gardell L.R., Ossipov M.H., Malan Jr. T.P., Vanderah T.W., Lai J., and Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 22 (2002) 5129-5136
10. de Boer T. The pharmacologic profile of mirtazapine. J. Clin. Psychiatry 57 Suppl. 4 (1996) 19-25
11. de Boer T., Maura G., Raiteri M., de Vos C.J., Wieringa J., and Pinder R.M. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers. Neuropharmacology 27 (1988) 399-408
12. Dodd S., Boulton D.W., Burrows G.D., De Vane C.L., and Norman T.R. In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes. Hum. Psychopharmacol.: Clin. Exp. 16 (2001) 541-544
13. Freynhagen R., Muth-Selbach U., Lipfert P., Stevens M.F., Zacharowski K., Tölle T.R., and von Giesen H.J. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr. Med. Res. Opin. 22 (2006) 257-264
14. Freynhagen R., Vogt J., Lipfert P., and Muth-Selbach U. Mirtazapine and its enantiomers differentially modulate acute thermal nociception in rats. Brain Res. Bull. 69 (2006) 168-173
15. Gower A., Broekkamp C., Rijk H., and Van Delft A. Pharmacological evaluation of in vivo tests for alpha 2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analog ORG 3770. Arch. Int. Pharmacodyn. Ther. 291 (1988) 185-201
16. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
17. Iyengar S., Webster A.A., Hemrick-Luecke S.K., Xu J.Y., and Simmons R.M.A. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311 (2004) 576-584
18. Jones C.K., Eastwood B.J., Need A.B., and Shannon H.E. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition. Neuropharmacology 51 (2006) 1172-1180
19. Kayser V., Elfassi I.E., Aubel B., Melfort M., Julius D., Gingrich J.A., Hamon M., and Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain 130 (2007) 235-248
20. Kooyman A.R., Zwart R., Vanderheijden P.M.L., Van Hooft J.A., and Vijverberg H.P.M. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology 33 (1994) 501-507
21. Leventhal L., Smith V., Hornby G., Andree T.H., Brandt M.R., and Rogers K.E. Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain. J. Pharmacol. Exp. Ther. 320 (2007) 1178-1185
22. Lu Y., and Perl E.R. Selective action of noradrenaline and serotonin on neurones of the spinal superficial dorsal horn in the rat. J. Physiol. 582 (2007) 127-136
23. McGrath C., Burrows G., and Norman T. Neurochemical effects of the enantiomers of mirtazapine in normal rats. Eur. J. Pharmacol. 356 2-3 (1998) 121-126
24. Moulin D.E., Clark A.J., Gilron I., Ware M.A., Watson C.P., Sessle B.J., Coderre T., Morley-Forster P.K., Stinson J., Boulanger A., Peng P., Finley G.A., Taenzer P., Squire P., Dion D., Cholkan A., Gilani A., Gordon A., Henry J., Jovey R., Lynch M., Mailis-Gagnon A., Panju A., Rollman G.B., and Velly A. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res. Manage. 12 (2007) 13-21
25. Muth-Selbach U., Dybek E., Kollosche K., Stegmann J., Holthusen H., Lipfert P., and Zeilhofer H.U. The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by d-serine. Anesthesiology 101 (2004) 753-758
26. Nadeson R., and Goodchild C.S. Antinociceptive role of 5-HT1A receptors in rat spinal cord. Br. J. Anaesth. 88 (2002) 679-684
27. Nitanda A., Yasunami N., Tokumo K., Fujii H., Hirai T., and Nishio H. Contribution of the peripheral 5-HT2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain. Neurochem. Int. 47 (2005) 394-400
28. Obata H., Saito S., Koizuka S., Nishikawa K., and Goto F. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Anesth. Analg. 100 (2005) 1406-1410
29. Pedersen L., Nielsen A., and Blackburn-Munro G. Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology 182 (2005) 551-561
30. Pertovaara A., and Wei H. Dual influence of the striatum on neuropathic hypersensitivity. Pain 137 (2008) 50-59
31. Reisner L. Antidepressants for chronic neuropathic pain. Curr. Pain Headache Rep. 7 (2003) 24-33
32. Ren K., and Dubner R. Descending modulation in persistent pain: an update. Pain 100 (2002) 1-6
33. Saarto T., and Wiffen P. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev. 4 (2007) CD005454
34. Schreiber S., Bleich A., and Pick C. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects-a possible opioid involvement in severe depression?. J. Mol. Neurosci. 18 1-2 (2002) 143-149
35. Schreiber S., Rigai T., Katz Y., and Pick C.G. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res. Bull. 58 (2002) 601-605
36. Sindrup S.H., Otto M., Finnerup N.B., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96 (2005) 399-409
37. Smith D.F., Marthi K., Munk O.L., Cumming P., Hansen S.B., and Jakobsen S. PET neuroimaging of [11C]mirtazapine enantiomers in pigs. Eur. Neuropsychopharmacol. 16 (2006) 350-357
38. Szegedi A., and Schwertfeger N. Mirtazapine: a review of its clinical efficacy and tolerability. Exp. Opin. Pharmacother. 6 (2005) 631-641
39. Theobald D.E., Kirsh K.L., Holtsclaw E., Donaghy K., and Passik S.D. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J. Pain Symptom Manage. 23 (2002) 442-447
40. Timmer C.J., Sitsen J.M., and Delbressine L.P. Clinical pharmacokinetics of mirtazapine. Clin. Pharmacokinet. 38 (2000) 461-474
41. Waters A.J., and Lumb B.M. Descending control of spinal nociception from the periaqueductal grey distinguishes between neurons with and without C-fibre inputs. Pain 134 (2008) 32-40
42. Yoshimura M., and Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J. Pharmacol. Sci. 101 (2006) 107-117
43. Zhu J., Wei X., Feng X., Song J., Hu Y., and Xu J. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-[kappa]B in a rat model of neuropathic pain. Neurosci. Lett. 433 (2008) 33-37